EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, InspireMD's enterprise value is $21.39 Mil.
InspireMD's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $6.48 Mil. Therefore, InspireMD's EV-to-Revenue for today is 3.30.
The historical rank and industry rank for InspireMD's EV-to-Revenue or its related term are showing as below:
NSPR'
s EV-to-Revenue Range Over the Past 10 Years
Min: -5.96 Med: -0.73 Max: 19.46
Current: 3.45
During the past 13 years, the highest EV-to-Revenue of InspireMD was 19.46. The lowest was -5.96. And the median was -0.73.
NSPR's EV-to-Revenue is ranked better than 53.68% of 829
companies
in the Medical Devices & Instruments industry
Industry Median: 3.27
vs NSPR: 3.45
As of today (2024-05-16), InspireMD's stock price is $2.30.
InspireMD's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.22. Therefore, InspireMD's PS Ratio for today is 10.45.
InspireMD EV-to-Revenue Historical Data
The historical data trend for InspireMD's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of InspireMD's EV-to-Revenue
For the Medical Devices subindustry, InspireMD's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InspireMD's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where InspireMD's EV-to-Revenue falls into.
InspireMD's current Enterprise Value is $21.39 Mil.
InspireMD's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InspireMD's share price for today is $2.30.
InspireMD's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InspireMD EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of InspireMD's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSPR has been successfully added to your 